z-logo
Premium
Suksdorfin Promotes Adipocyte Differentiation and Improves Abnormalities in Glucose Metabolism via PPARγ Activation
Author(s) -
Iwase Mari,
Yamamoto Takayuki,
Nishimura Kanako,
Takahashi Haruya,
Mohri Shinsuke,
Li Yongjia,
Jheng HueiFen,
Nomura Wataru,
Takahashi Nobuyuki,
Kim ChuSook,
Yu Rina,
Taniguchi Masahiko,
Baba Kimiye,
Murakami Shigeru,
Kawada Teruo,
Goto Tsuyoshi
Publication year - 2017
Publication title -
lipids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.601
H-Index - 120
eISSN - 1558-9307
pISSN - 0024-4201
DOI - 10.1007/s11745-017-4269-7
Subject(s) - adipogenesis , adipocyte , medicine , endocrinology , peroxisome proliferator activated receptor , adipokine , adiponectin , adipose tissue , biology , chemistry , receptor , diabetes mellitus , insulin resistance
Although the Apiaceae herb family has been traditionally used for the management of type 2 diabetes, its molecular mechanism has not been clarified. Coumarin derivatives, which are abundant in plants of the Apiaceae family, were evaluated for their effects on adipogenesis. We found that suksdorfin significantly promoted adipocyte differentiation and enhanced production of adiponectin, an anti‐diabetic adipokine. We also demonstrated that suksdorfin activates peroxisome proliferator‐activated receptor gamma (PPARγ), a master regulator of adipogenesis. Furthermore, we showed metabolic disorders in obese diabetic KK‐A y mice were attenuated by suksdorfin feeding. Suksdorfin intake induced adipocyte miniaturization and increased expression levels of PPARγ target genes related to adipocyte differentiation. These results indicated that suksdorfin induces adipogenesis in white adipose tissue (WAT) via the activation of PPARγ, leading to improvement of obesity‐induced metabolic disorders. Therefore, suksdorfin‐mediated amelioration of WAT dysfunctions might be responsible for the anti‐diabetic effects of traditional herbal medicine therapy with Apiaceae .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here